RC25
Retatrutide 20mg + Cagrilintide 5mg
This co-formulated product is supplied as a lyophilized solid in vials for research purposes.
Highlights
- Co-formulated lyophilized solid.
- Single 25mg per vial configuration.
- Full lot history available.
Typical research applications
- Assay calibration standard.
- Research protocol validation.
Lot and handling notes
The material consists of a blended lyophilized cake within each vial, with a total mass of 25mg per unit. Comprehensive manufacturing records are maintained for every production lot.
It is offered in a single packaging option containing ten vials. This product is intended solely for in vitro laboratory investigation.
Specifications
| Product | |
|---|---|
| Abbreviation | RC25 |
| Form | Lyophilized material |
| Pack sizes | 25mg*10vials |
| Analysis | |
| Measured content | 25mg: Retatrutide 21.94MG + Cagrilintide 5.70mg |
| Documentation | |
| Lot record | Supplied with every order |